Page 55 - IJB-10-6

International Journal of Bioprinting Semi-solid extrusion for pediatric medicine

Continued
Ref. 102 103 104 105 106 107 108 109 110

Commentaries Evaluation of the feasibility of SSE 3D printing hospital preparations for children Evaluation of different gum formulations; gelatin improves printability; carrageenan improves thermal stability and disintegration rate of dosage forms Development of a dosage form for API release, modified by modulating the carboxymethyl chitosan/sodium alginate ratio and the filling density using SSE 3D printing Evaluation of five PVA/PVAc copolymer

D-mannitol, maltitol, carboxymethyl cellulose sodium type 800 mPa/s, sodium starch glycolate type lippin, sucralose, methylparaben, soybean oil, anhydrous citric acid, sodium citrate, FD&C Sodium carboxymethyl starch; gelatin; carrageenan; γ-aminobutyric acid Carboxymethyl chitosan, sodium alginate, Cellulose; manitole; CMS-Na; PVP Tween 80, esters of polyglycerol and stearic acid, Eumulgin SMO 20, polyethylene oxide Carboxymethyl cellul

Excipients yellow n°5 PEGDA, TPO Copolymer PVA/PVAc durian rind wastes

Amlodipine besylate hydrochloride Bovine serum Hydrochlorothiazide Eucalyptus extract Triamcinolone Theophylline Nano-piroxicam

API Propranolol protein Loratadine acetonide (7.5%)

Formulation details and properties Immediate-release printlets for pediatric use Immediate-release gummy chewable printlets for pediatrics pH-responsive polypills for delayed drug release Swallowable films with several modified drug release profiles Immediate-release printlets Immediate-release swallowable films Sustained release swallowable films Films with four different structures based on carboxymethyl cellulose ink from

Table 1. Continued Formulation type Chewable printlets Polypill (printlet) Swallowable films

Volume 10 Issue 6 (2024) 47 doi: 10.36922/ijb.4063